Cytometric catheter for neurosurgical applications

Journal of Medical Engineering and Technology

Volumn 34, Issue 4, 2010, Pages 261-267

  Evans III, B M ^a   Allison, S W ^a   Fillmore, H L ^b   Broaddus, W C ^b   Dyer, R L ^a   Gillies, G T ^b,c  

^a OAK RIDGE NATIONAL LABORATORY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c University of Virginia   (United States)

Author keywords

Cell therapy; Fibre optics; Flow cytometry; Neurocatheter; Positive pressure infusion

Indexed keywords

A-COEFFICIENT; CELL DENSITY; CELL THERAPY; CENTRAL NERVOUS SYSTEMS; FIBRE OPTIC; FIBRE OPTICS; FIBRE-OPTIC PROBE; NEURAL CELLS; NEURAL PROGENITOR CELLS; PARKINSON'S DISEASE; POSITIVE PRESSURE; REPLACEMENT STRATEGY; TESTING DATA;

CATHETERS; CELLS; DISEASES; FLOW CYTOMETRY; FLUORESCENCE; OPTOELECTRONIC DEVICES;

CYTOLOGY;

ANIMAL; ARTICLE; BIOLOGICAL THERAPY; CATHETERIZATION; EQUIPMENT DESIGN; HUMAN; INSTRUMENTATION; METHODOLOGY; NEUROSURGERY;

ANIMALS; CATHETERIZATION; EQUIPMENT DESIGN; HUMANS; NEUROSURGICAL PROCEDURES; TISSUE THERAPY;

EID: 77951272035     PISSN: 03091902     EISSN: 1464522X     Source Type: Journal    
DOI: 10.3109/03091901003639943     Document Type: Article

References (24)

1. Parkinson's Disease Foundation, 2006, Ten frequently-asked questions about Parkinson's disease (New York, NY: Parkinson's Disease Foundation). Available online at: www.pdf.org. (accessed 2 January 2008).
2. Fillmore, H.L., Holloway, K.L. and Gillies, G.T., 2005, Cell replacement efforts to repair neuronal injury: a potential paradigm for the treatment of Parkinson's disease. NeuroRehabilitation, 20, 233-242.
3. Brudin, P., Bargin, G., Isacson, O., Mallat, M., Chamak, B., Prochintz, A., Gage, G.H. and Bjö rklund, A., 1985, Survival of intracerebrally grafted rat dopamine neurons previously cultured in vitro. Neuroscience Letters, 61, 79-84. (Pubitemid 16201128)
4. Freed, C.R., Greene, P.E., Breeze, R.E., Tsai, W.Y., DuMouchel, W., Kao, R., Dillon, S., Winfield, H., Culver, S., Trojanowski, J.Q., Eidelberg, D. and Fahn, S., 2001, Transplantation of embryonic dopamine neurons for severe Parkinson's disease. New England Journal of Medicine, 344, 710-719. (Pubitemid 32204988)
5. Freed, C.R., Leehey, M.A., Zawada, M., Bjugstad, K., Thompson, L. and Breeze, R.E., 2003, Do patients with Parkinson's disease benefit from embryonic dopamine cell transplantation? Journal of Neurology, 250 Suppl 3, 44-46.
6. Bjorklund, A., Dunnett, S.B., Brundin, P., Stoessl, A.J., Freed, C.R., Breeze, R.E., Levivier, M., Peschanski, M., Studer, L. and Barker, R., 2003, Neural transplantation for the treatment of Parkinson's disease. Lancet Neurology, 2, 437-445. (Pubitemid 36793939)
7. Kordower, J.H., Freeman, T.B., Snow, B.J., Vingerhoets, F.J., Mufson, E.J., Sanberg, P.R., Hauser, R.A., Smith,D.A.,Nauert, G.M., Perl, D.P. and Olanow, C.W., 1995, Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. New England Journal of Medicine, 332, 1118-1124.
8. Studer, L., Tabar, V. and McKay, R.D., 1998, Transplantation of expanded mesencephalic precursors leads to recovery in parkinsonian rats. Nature Neuroscience, 1, 290-295. (Pubitemid 128652675)
9. Nikkhah, G., Cunningham, M.G., Jodicke, A., Knappe, U. and Bjorklund, A, 1994, Improved graft survival and striatal reinnervation by microtransplantation of fetal nigral cell suspensions in the rat Parkinson model. Brain Research, 633, 133-143. (Pubitemid 24021254)
10. Bjorklund, L.M., Sanchez-Pernaute, R., Chung, S., Andersson, T., Chen, I.Y., McNaught, K.S., Brownell, A.L., Jenkins, B.G., Wahlestedt, C., Kim, K.S. and Isacson, O., 2002 Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proceedings of the Natlional Academy of Science USA, 99, 2344-2349. (Pubitemid 34169063)
11. Richardson, R.M., Fillmore, H.L., Holloway, K.L. and Broaddus, W.C., 2004, Progress in cerebral transplantation of expanded neuronal stem cells. Journal of Neurosurgery, 100, 659-671.
12. Rosenstein, J.M., 1995, Why do neural transplants survive? An examination of some metabolic and pathophysiological considerations in neural transplantation. Experimental Neurology, 133, 1-6.
13. Sladek Jr, J.R., Collier, T.J., Elsworth, J.D., Roth, R.H., Taylor, J.R. and Redmond Jr, D.E., 1998, Intrastriatal grafts from multiple donors do not result in a proportional increase in survival of dopamine neurons in nonhuman primates. Cell Transplantation, 7, 87-96.
14. Dziewczapolski, G., Lie, D.C., Ray, J., Gage, F.H. and Shults, C.W., 2003, Survival and differentiation of adult rat-derived neural progenitor cells transplanted to the striatum of hemiparkinsonian rats. Experimental Neurology, 183, 653-664. (Pubitemid 37205108)
15. Watts, C., Caldwell, M.A. and Dunnett, S.B., 1998, The development of intracerebral cell-suspension implants is influenced by the grafting medium. Cell Transplantation, 7, 573-583 (Pubitemid 28548993)
16. Redmond Jr., D.E., 2002, Cellular replacement therapy for Parkinson's disease-where we are today? Neuroscientist, 8, 457-488.
17. Stokes, B.T. and Reier, P.J., 1991, Oxygen transport in intraspinal fetal grafts: graft-host relations. Experimental Neurology, 111, 312-323.
18. Clarkson, E.D., Zawada, W.M., Bell, K.P., Esplen, J.E., Choi, P.K., Heidenreich, K.A. and Freed, C.R., 2001, IGF-I and bFGF improve dopamine neuron survival and behavioral outcome in parkinsonian rats receiving cultured human fetal tissue strands. Experimental Neurology, 168, 183-191.
19. Zawada, W.M., Zastrow, D.J., Clarkson, E.D., Adams, F.S., Bell, K.P. and Freed, C.R., 1998, Growth factors improve immediate survival of embryonic dopamine neurons after transplantation into rats. Brain Research, 786, 96-103.
20. Fillmore, H.L., Allison, S.W., Evans III, B.M., Goedeke, S.M., Boudreaux, P.R. and Gillies, G.T., 2006, Preliminary results from laboratory tests of a prototype catheter for monitoring cell delivery into the CNS. University of Virginia School of Engineering and Applied Science Technical Report UVA/640419/MAE06/101.
21. Barth, R.F., 1998, Rat brain tumor models in experimental neurooncology: The 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 Gliomas. Journal of Neuro-Oncology, 36, 91-102.
22. Fillmore, H.L., Shurm, J., Furqueron, P., Prabhu, S.S., Gillies, G.T. and Broaddus, W.C., 1999, An in vivo rat model for visualizing glioma tumor cell invasion using stable persistent expression of the green fluorescent protein. Cancer Letters, 141, 9-19. (Pubitemid 29261716)
23. Chen, Z.J., Gillies, G.T., Broaddus, W.C., Prabhu, S.S., Fillmore, H., Mitchell, R.M., Corwin, F.D. and Fatouros, P.P., 2004, A realistic brain tissue phantom for intraparenchymal infusion studies. Journal of Neurosurgery, 101, 314-322. (Pubitemid 38971010)
24. Gillies, G.T. and Allison, S., 1986, Precision limits of lock-in amplifiers below unity signal-to-noise ratios. Review of Scientific Instruments, 57, 268-270.Instruments, 57, 268-270.